City of Hope
Physician Leader| Cutaneous Oncology Enterprise Leader | Duarte, CA
City of Hope, Duarte, California, United States, 91010
Our vision at City of Hope is to create a world-class Cutaneous Oncology Program that brings together clinicians, clinician scientists and
and laboratory researchers across the institution to gain a better understanding of cutaneous oncology and to develop better treatments, screening methods, prevention strategies and survivorship care for them.
Our outpatient facility located on our Duarte, CA campus serves as a central hub for patients to have access to the full range of health care professionals, including not only physician specialists, but nurses, genetic counselors, schedulers, social workers, financial counselors, supportive care staff and other health specialists. In addition, our reach extends throughout our extensive network for care delivery.
Our cutaneous oncology program is comprised of extensive dedicated disease teams that drive translational research at COH National Cancer Institute with many open trials.
The Opportunity
City of Hope has launched a national search for a Cutaneous Oncology Enterprise Leader (Physician) who will develop and provide enterprise leadership to an enterprise-wide cutaneous oncology program in clinical, research, and educational areas. The Cutaneous Oncology Enterprise Leader will be a highly regarded physician scientist with a collaborative, team-based leadership style, and the ability to leverage and grow the current program to become a nationally recognized cutaneous oncology program . He/she must also be operationally savvy, with the business acumen and cultural sensitivity to lead within a complex, matrixed environment having direct reporting to their respective specialty chair and working collaboratively with leaders across disciplines. The leader must possess a breadth of skills, including demonstrated ability to drive research productivity; deep knowledge of clinical practice; a strong commitment to training and career development faculty and trainees; and demonstrated leadership and administrative ability in the clinical enterprise.
There are specific priorities that COH seeks from the Executive to deliver with an overall objective of elevating the cutaneous oncology program nationally. The following are of particular importance:
·
Provide broad vision and leadership to the cutaneous oncology program in research and clinical care delivery throughout the enterprise that will further advance our reputation and delivery of care on the national stage
·
Expand and scale clinical trials and translational research to patients throughout City of Hope enterprise
·
Drive and standardize care pathways achieving superior quality delivering excellence in patient outcomes, patient experience and utilization metrics.
·
Integrate throughout the enterprise and expand our current cutaneous oncology program
by recruiting high caliber physicians and physician scientists creating market differentiation and excellence.
·
Establish and lead a Center of Excellence in Cutaneous Oncology in Southern California building a multi-disciplinary team including dermatology, oncology, surgery, pathology and radiation oncology specialists focused on the delivery of advance therapies, including clinical trials, to patients.
About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
City of Hope is an equal opportunity employer.
and laboratory researchers across the institution to gain a better understanding of cutaneous oncology and to develop better treatments, screening methods, prevention strategies and survivorship care for them.
Our outpatient facility located on our Duarte, CA campus serves as a central hub for patients to have access to the full range of health care professionals, including not only physician specialists, but nurses, genetic counselors, schedulers, social workers, financial counselors, supportive care staff and other health specialists. In addition, our reach extends throughout our extensive network for care delivery.
Our cutaneous oncology program is comprised of extensive dedicated disease teams that drive translational research at COH National Cancer Institute with many open trials.
The Opportunity
City of Hope has launched a national search for a Cutaneous Oncology Enterprise Leader (Physician) who will develop and provide enterprise leadership to an enterprise-wide cutaneous oncology program in clinical, research, and educational areas. The Cutaneous Oncology Enterprise Leader will be a highly regarded physician scientist with a collaborative, team-based leadership style, and the ability to leverage and grow the current program to become a nationally recognized cutaneous oncology program . He/she must also be operationally savvy, with the business acumen and cultural sensitivity to lead within a complex, matrixed environment having direct reporting to their respective specialty chair and working collaboratively with leaders across disciplines. The leader must possess a breadth of skills, including demonstrated ability to drive research productivity; deep knowledge of clinical practice; a strong commitment to training and career development faculty and trainees; and demonstrated leadership and administrative ability in the clinical enterprise.
There are specific priorities that COH seeks from the Executive to deliver with an overall objective of elevating the cutaneous oncology program nationally. The following are of particular importance:
·
Provide broad vision and leadership to the cutaneous oncology program in research and clinical care delivery throughout the enterprise that will further advance our reputation and delivery of care on the national stage
·
Expand and scale clinical trials and translational research to patients throughout City of Hope enterprise
·
Drive and standardize care pathways achieving superior quality delivering excellence in patient outcomes, patient experience and utilization metrics.
·
Integrate throughout the enterprise and expand our current cutaneous oncology program
by recruiting high caliber physicians and physician scientists creating market differentiation and excellence.
·
Establish and lead a Center of Excellence in Cutaneous Oncology in Southern California building a multi-disciplinary team including dermatology, oncology, surgery, pathology and radiation oncology specialists focused on the delivery of advance therapies, including clinical trials, to patients.
About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
City of Hope is an equal opportunity employer.